The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
Low-dose naltrexone shows promise for long COVID
New Zealand Doctor Rata Aotearoa
David Codyre
Wednesday 8 January 2025
Psychiatrist David Codyre reviews the growing evidence for low-dose naltrexone in the treatment of functional syndromes such as fibromyalgia, chronic fatigue and long COVID
Key points, In low doses (typically 3–4.5mg daily), naltrexone appears to modulate ...
Subscription required: Follow link i f you have, or want, a subscription to this medical website
Journal of Pain and Palliative Care Pharmacotherapy
2024 Jun 5:1-8
A Utilization Review of Patients That Respond to Low-Dose Naltrexone (LDN) for Chronic Pain at a Single Institution
Joshua Pogue, Diane Johnson & Andrew Burch
The Korean Journal of Pain
2024 Oct 1;37(4):367-378
Akhil Deepak Vatvani, Pratik Patel, Timotius Ivan Hariyanto & Theo Audi Yanto
Melanie, a resident of Canada, went through a challenging journey of coping with multiple health conditions such as MCAS, POTS, Sjogren’s, Fibromyalgia, Asthma, and Hashimoto's.
A local pharmacy compounds medicine that’s helping many lives
by: Taylor Aasen
Posted: Aug 23, 2024 / 11:19 AM CDT
Updated: Aug 23, 2024 / 11:21 AM CDT
https://www.kxnet.com/news/top-stories/a-local-pharmacy-compounds-medicine-thats-helping-many-lives/
I’ve lost everything: Globetrotting DJ bedbound by long Covid says condition cost him career, friends and mobility
Staff Reporter10 May 2024
Low Dose Naltrexone: Is it Really Worth the Hype?
Nov 6, 2023, by Priyanka Singla, MD, Yasmin Sritapan, DO, and Bhavana Yalamuru, MD
The People's Pharmacy: Could low-dose naltrexone ease arthritis pain?
JOE AND TERESA GRAEDON Special correspondents 28th April 2024